Bend Research Receives EU Certificate of GMP Compliance

first_img Share. 0 The local independent drug-formulation development and manufacturing company has received certification of compliance with European Union (EU) Good Manufacturing Practice (GMP) regulations.This broad certification, which was granted by Sweden’s Medical Products Agency (MPA), covers Bend Research’s manufacture of clinical pharmaceutical supplies for human consumption and testing of those supplies at the company’s GMP facilities.“The strategic addition of this certification—combined with new capabilities such as high-potency spray-drying and future commercial spray-drying—strengthens Bend Research’s position as a preferred provider for oral solubilized, modified-release, inhalation, and many other dosage forms,” said Rod Ray, Bend Research CEO.“We knew the EU’s quality standards were stringent, but we were confident that our operations met those high standards and were eager to demonstrate that to our customers,” Ray said.In 2012, Bend Research produced clinical supplies for 16 clients, 37 chemical compounds and 136 clinical manufacturing lots. Many of these involved the use of advanced dosage forms designed to increase the exposure of low-solubility compounds or provide modified-release delivery profiles.Bend Research requested the voluntary inspection by the MPA and certification was granted after an audit of operations by the MPA. Bend Research Receives EU Certificate of GMP Compliance 64550 Research Road, Bend, Oregon 97701 USA | 800.706.8655 | Email Twitter Bend Research Receives EU Certificate of GMP Compliance By CBN on January 31, 2013center_img Facebook Google+ Pinterest LinkedIn Tumblr E-Headlineslast_img read more